Sociodemographic and obstetric features of the patients followed in a protocol of prevention of the mother-child transmission of the HIV1 in the Sylvanus Olympio teaching hospital

Tunis Med. 2017 Dec;95(12):229-234.

Abstract

Introduction: Preventing mother-to-child transmission (PMTCT) of HIV decreases new HIV infections in children. The objectives of our study were to describe the sociodemographic and obstetric characteristics of the patients of a protocol for the PMTCT of HIV-1 in Sylvanus Olympio Teaching Hospital.

Methods: We conducted a prospective cross-sectional descriptive study of the follow-up cohort type in the PMTCT siteof Sylvanus Olympio Teaching Hospital. It extended from 27 June 2011 to 27 May 2015.

Results: A total of 255 women were included. The average age of our patients was 30 years old with extremes of 18 and 45 years old. Resellers were 38.8% and housewives accounted for 17.6%. 48.2% of our patients had completed high school. Single persons accounted for 36.1% and 54.5% were married monogamous. Sixty-four percent of the patients were HIV-positive during pregnancy and 80.7% were in WHO clinical stage I. Only 17.3% of the patients had consulted the first time in the first trimester of pregnancy.

Conclusion: The results of this study reveal that the majority of our patients were young, asymptomatic and were mostly screened in our maternity ward.

MeSH terms

  • Adolescent
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Cohort Studies
  • Cross-Sectional Studies
  • Female
  • HIV Infections / epidemiology*
  • HIV Infections / prevention & control
  • HIV Infections / therapy*
  • HIV Infections / transmission
  • HIV-1
  • Hospitals, Teaching
  • Humans
  • Infant, Newborn
  • Infection Control / methods
  • Infection Control / organization & administration
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnancy Complications, Infectious / therapy*
  • Togo / epidemiology
  • Young Adult

Substances

  • Anti-HIV Agents